Source: Eur Respir J, 52 (4) 1800599; 10.1183/13993003.00599-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Victoria Connor, Esther German, Sherin Pojar, Elena Mitsi, Caroline Hales, Elissavet Nikolaou, Angela Hyder-Wright, Hugh Adler, Seher Zaidi, Helen Hill, Simon P. Jochems, Hassan Burhan, Neil French, Timothy Tobery, Jamie Rylance, Daniela M. Ferreira. Hands are vehicles for transmission of Streptococcus pneumoniae in novel controlled human infection study. Eur Respir J, 52 (4) 1800599; 10.1183/13993003.00599-2018

Member's Comments

No comment yet.

Related content which might interest you: Streptococcus pneumoniae resistance pattern and its clinical implications Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Source: Eur Respir J 2001; 17: 241-245 Year: 2001 Streptococcus pneumoniae is the main causative agent of community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 608s Year: 2002 Chlamidia pneumoniae and Mycoplasma pneumoniae infection of airways in patients with broncho-obstructive diseases Source: Eur Respir J 2005; 26: Suppl. 49, 409s Year: 2005 Relationship between the inoculum dose of Streptococcus pneumoniae and pneumonia onset in a rabbit model Source: Eur Respir J 2005; 25: 693-700 Year: 2005 Clinical features of Mycoplasma pneumoniae infections in Bulgarian children Source: Virtual Congress 2020 – Epidemiology of paediatric respiratory diseases Year: 2020 Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways in patients with bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Influence of streptococcus pneumoniae serotypes in clinical outcomes of pneumonias Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Comparative study of S. milleri as a cause of community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 373s Year: 2006 Macrolide-resistant mycoplasma pneumoniae in respiratory tract infection and its clinical relevance Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Genetic diversity of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolates from community acquired pneumonia (CAP) in china Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Community-acquired pneumonia in Europe: causative pathogens and resistance patterns Source: Eur Respir J 2002; 20: 20S-27S Year: 2002 Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia? Source: Eur Respir J 2003; 21: 741-742 Year: 2003 Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006